Trial intelligence / Profile preview

Nano-lipid curcumin-luteolin formulation for moderate eczema

TCTR20260220001Phase 1Not yet recruiting

Sponsor
Muhammad Nawaz Sharif University of Agriculture
Start
Mar 2026
Modality
Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1 trial of curcumin and luteolin in atopic dermatitis (AD), sponsored by Muhammad Nawaz Sharif University of Agriculture. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

curcuminluteolin
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on TCTR20260220001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260220001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call